Trial intelligence / Profile preview

Dexmedetomidine vs propofol vs sevoflurane anesthesia in infants with cyanotic congenital heart disease undergoing cardiac surgery

ChiCTR-TRC-12002788Phase 4Completed

Sponsor
First Affiliated Hospital of Anhui Medical University
Start
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of dexmedetomidine, propofol and sevoflurane in Cardiovascular Malformation (CVM) (3 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Hospital stay and Mortality rate. Started Mar 2012; status: completed.

02

Drugs

dexmedetomidinepropofolsevoflurane
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ChiCTR-TRC-12002788.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-12002788.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call